RANCATI, TIZIANA
 Distribuzione geografica
Continente #
NA - Nord America 3.046
EU - Europa 2.792
AS - Asia 2.409
SA - Sud America 188
AF - Africa 65
OC - Oceania 43
Continente sconosciuto - Info sul continente non disponibili 3
Totale 8.546
Nazione #
US - Stati Uniti d'America 2.958
DE - Germania 1.277
CN - Cina 775
SG - Singapore 694
IT - Italia 328
GB - Regno Unito 321
BD - Bangladesh 234
SE - Svezia 209
HK - Hong Kong 205
VN - Vietnam 196
RU - Federazione Russa 184
BR - Brasile 143
IN - India 100
FR - Francia 90
NL - Olanda 82
IE - Irlanda 80
CA - Canada 64
FI - Finlandia 54
ID - Indonesia 44
AU - Australia 39
JP - Giappone 32
DK - Danimarca 30
CI - Costa d'Avorio 27
ES - Italia 24
UA - Ucraina 23
BE - Belgio 20
PH - Filippine 19
KR - Corea 16
TR - Turchia 16
AT - Austria 15
CH - Svizzera 14
IQ - Iraq 14
MX - Messico 13
TW - Taiwan 13
AR - Argentina 11
CO - Colombia 11
PL - Polonia 9
TH - Thailandia 9
EC - Ecuador 7
EG - Egitto 7
MA - Marocco 7
CL - Cile 6
RO - Romania 6
ZA - Sudafrica 6
KE - Kenya 5
PK - Pakistan 5
TN - Tunisia 5
AE - Emirati Arabi Uniti 4
BG - Bulgaria 4
GR - Grecia 4
PE - Perù 4
SA - Arabia Saudita 4
UZ - Uzbekistan 4
IR - Iran 3
JM - Giamaica 3
JO - Giordania 3
KZ - Kazakistan 3
LK - Sri Lanka 3
MU - Mauritius 3
NO - Norvegia 3
NZ - Nuova Zelanda 3
PT - Portogallo 3
UY - Uruguay 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AL - Albania 2
AM - Armenia 2
AZ - Azerbaigian 2
CZ - Repubblica Ceca 2
HU - Ungheria 2
LT - Lituania 2
MY - Malesia 2
PA - Panama 2
PY - Paraguay 2
SC - Seychelles 2
BS - Bahamas 1
BY - Bielorussia 1
DO - Repubblica Dominicana 1
EE - Estonia 1
EU - Europa 1
FJ - Figi 1
GA - Gabon 1
GE - Georgia 1
GT - Guatemala 1
HN - Honduras 1
HR - Croazia 1
KH - Cambogia 1
LV - Lettonia 1
MN - Mongolia 1
MO - Macao, regione amministrativa speciale della Cina 1
MV - Maldive 1
NG - Nigeria 1
NI - Nicaragua 1
NP - Nepal 1
PS - Palestinian Territory 1
SD - Sudan 1
VE - Venezuela 1
VG - Isole Vergini Britanniche 1
Totale 8.546
Città #
Frankfurt am Main 1.135
Ashburn 528
Singapore 401
Chandler 306
Southend 227
San Jose 184
Hong Kong 171
Houston 147
Dallas 132
Milan 127
Santa Clara 122
Beijing 108
Princeton 96
Fairfield 88
Council Bluffs 84
Dearborn 81
Los Angeles 80
Dublin 76
Shanghai 73
New York 66
Wilmington 61
Seattle 54
Ho Chi Minh City 52
Woodbridge 52
Cambridge 47
Fuzhou 44
Ann Arbor 43
Des Moines 43
Lauterbourg 43
Hanoi 42
Buffalo 41
Columbus 39
Helsinki 39
Moscow 39
Nanjing 38
Grafing 36
The Dalles 32
Guangzhou 31
Redwood City 31
Berlin 29
Jakarta 28
Abidjan 27
Bengaluru 23
Central District 23
Jinan 23
Phoenix 23
Munich 22
Suzhou 21
Toronto 21
Shenyang 18
Rome 17
Boardman 16
Cangzhou 16
São Paulo 16
Hebei 15
Changsha 14
Da Nang 14
Tokyo 14
Brussels 13
Dong Ket 13
Pune 13
Shenzhen 13
Boston 10
Naples 10
Nuremberg 10
Eitensheim 9
Haiphong 9
Nanchang 9
Rotterdam 9
San Diego 9
Taipei 9
Tianjin 9
Zhengzhou 9
Amsterdam 8
Calgary 8
Chicago 8
Falls Church 8
Hangzhou 8
London 8
Mumbai 8
San Francisco 8
Vienna 8
Atlanta 7
Chengdu 7
Jiaxing 7
Melbourne 7
Washington 7
Baltimore 6
Brooklyn 6
Montreal 6
Ottawa 6
Quanzhou 6
Redmond 6
Rio de Janeiro 6
Warsaw 6
Wuhan 6
Bogotá 5
Guayaquil 5
Hefei 5
Kunming 5
Totale 5.754
Nome #
The Movember Foundation's GAP3 cohort : a profile of the largest global prostate cancer active surveillance database to date 520
Baseline status and dose to the penile bulb predict impotence 1 year after radiotherapy for prostate cancer 368
REQUITE : a prospective multicentre cohort study of patients undergoing radiotherapy for breast, lung or prostate cancer 339
MiR-205 enhances radiation sensitivity of prostate cancer cells by impairing DNA damage repair through PKCϵ and ZEB1 inhibition 332
Core Biopsies from Prostate Cancer Patients in Active Surveillance Protocols Harbor PTEN and MYC Alterations 292
Evaluation of mediators associated with the inflammatory response in prostate cancer patients undergoing radiotherapy 276
A Deep Learning Approach Validates Genetic Risk Factors for Late Toxicity After Prostate Cancer Radiotherapy in a REQUITE Multi-National Cohort 276
Modelling radiation‐induced salivary dysfunction during IMRT and chemotherapy for nasopharyngeal cancer patients 261
Development of a Ready-to-Use Graphical Tool Based on Artificial Neural Network Classification : Application for the Prediction of Late Fecal Incontinence After Prostate Cancer Radiation Therapy 249
Multivariable model for predicting acute oral mucositis during combined IMRT and chemotherapy for locally advanced nasopharyngeal cancer patients 235
Multi-variable models predicting specific patient-reported acute urinary symptoms after radiotherapy for prostate cancer : results of a cohort study 231
Baseline mri-radiomics can predict overall survival in non-endemic ebv-related nasopharyngeal carcinoma patients 231
Genetic Variants Predict Optimal Timing of Radiotherapy to Reduce Side-effects in Breast Cancer Patients 230
Prediction of grade reclassification of prostate cancer patients on active surveillance through the combination of a three-mirna signature and selected clinical variables 226
Development of a method for generating SNP interaction-aware polygenic risk scores for radiotherapy toxicity 224
Daily sodium butyrate enema for the prevention of radiation proctitis in prostate cancer patients undergoing radical radiation therapy : Results of a multicenter randomized placebo-controlled dose-finding phase 2 study 216
Acute patient-reported intestinal toxicity in whole pelvis IMRT for prostate cancer : Bowel dose-volume effect quantification in a multicentric cohort study 216
Comment on "objective assessment in digital images of skin erythema caused by radiotherapy" [Med. Phys. 42, 5568-5577 (2015)] 205
Predicting Late Fecal Incontinence Risk After Radiation Therapy for Prostate Cancer : New Insights From External Independent Validation 204
Relationships between bladder dose-volume/surface histograms and acute urinary toxicity after radiotherapy for prostate cancer 203
Texture analysis of T1-w and T2-w MR images allows a quantitative evaluation of radiation-induced changes of internal obturator muscles after radiotherapy for prostate cancer 183
Long term rectal function after high-dose prostatecancer radiotherapy : results from a prospective cohort study 179
The 6-year attendance of a multidisciplinary prostate cancer clinic in Italy : incidence of management changes 172
Impact of the radiotherapy technique on the correlation between dose-volume histograms of the bladder wall defined on MRI imaging and dose-volume/surface histograms in prostate cancer patients 171
Predictors of patient-reported incontinence at adjuvant/salvage radiotherapy after prostatectomy : Impact of time between surgery and radiotherapy 165
Predictors of health-related quality of life and adjustment to prostate cancer during active surveillance 164
Correlation between surrogates of bladder dosimetry and dose-volume histograms of the bladder wall defined on MRI in prostate cancer radiotherapy 161
Breast cancer patient perspective on opportunities and challenges of a genetic test aimed to predict radio-induced side effects before treatment : Analysis of the Italian branch of the REQUITE project 157
Dose-volume effects for normal tissues in external radiotherapy : pelvis 154
Editorial Comment to Health-related quality of life after carbon-ion radiotherapy for prostate cancer : A 3-year prospective study 146
Predictive models of toxicity with external radiotherapy for prostate cancer: Clinical issues 135
Editorial : Modeling for Prediction of Radiation-Induced Toxicity to Improve Therapeutic Ratio in the Modern Radiation Therapy Era 131
Fitting late rectal bleeding data using different NTCP models : Results from an Italian multi-centric study (AIROPROS0101) 129
Italian cultural adaptation of the Memorial Anxiety for Prostate Cancer scale for the population of men on active surveillance 124
Inclusion of clinical risk factors into NTCP modelling of late rectal toxicity after high dose radiotherapy for prostate cancer 114
Reducing rectal injury during external beam radiotherapy for prostate cancer 111
Clinical and dosimetric predictors of late rectal toxicity after conformal radiation for localized prostate cancer : results of a large multicenter observational study 111
Long-term biochemical control of prostate cancer after standard or hyper-fractionation : evidence for different outcomes between low-intermediate and high risk patients 99
Contouring variability of the penile bulb on CT images : quantitative assessment using a generalized concordance index 99
Is it time to tailor the prediction of radio-induced toxicity in prostate cancer patients? Building the first set of nomograms for late rectal syndrome 97
miRNAs in tumor radiation response : bystanders or participants? 96
Predictive models of toxicity in external radiotherapy : dosimetric issues 94
Late fecal incontinence after high-dose radiotherapy for prostate cancer : better prediction using longitudinal definitions 94
Increasing the risk of late rectal bleeding after high-dose radiotherapy for prostate cancer : the case of previous abdominal surgery. Results from a prospective trial 88
To Bleed or Not to Bleed : a Prediction Based on Individual Gene Profiling Combined With Dose-Volume Histogram Shapes in Prostate Cancer Patients Undergoing Three-Dimensional Conformal Radiation Therapy 85
Predictors for Rectal and Intestinal Acute Toxicities During Prostate Cancer High-Dose 3D-CRT : Results of a Prospective Multicenter Study 85
Development of a Set of Nomograms to Predict Acute Lower Gastrointestinal Toxicity for Prostate Cancer 3D-CRT 83
Reply from Authors re: Laurence Klotz. Active surveillance, quality of life, and cancer-related anxiety. Eur Urol 2013;64:37-9: Active surveillance: Risk and protective factors for quality of life 79
Totale 8.840
Categoria #
all - tutte 22.161
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 22.161


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202151 0 0 0 0 0 0 0 0 0 0 0 51
2021/2022668 34 29 22 38 76 41 54 32 65 54 35 188
2022/2023852 139 85 85 101 78 158 13 49 85 13 36 10
2023/20241.353 13 31 27 14 89 61 170 379 72 146 168 183
2024/20251.545 153 172 123 212 157 46 33 110 56 91 145 247
2025/20262.777 221 127 213 204 270 193 397 109 288 187 352 216
Totale 8.840